ARS Pharmaceuticals Ownership | Who Owns ARS Pharmaceuticals?
ARS Pharmaceuticals Ownership Summary
ARS Pharmaceuticals is owned by 49.86% institutional investors, 16.82% insiders, and 33.32% retail investors. Ra capital management is the largest institutional shareholder, holding 11.04% of SPRY shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 2.00% of its assets in ARS Pharmaceuticals shares.
SPRY Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | ARS Pharmaceuticals | 49.86% | 16.82% | 33.32% |
| Sector | Healthcare Stocks | 231.98% | 10.74% | -142.72% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ra capital management | 10.86M | 11.04% | $109.15M |
| Orbimed advisors | 8.29M | 8.43% | $83.30M |
| Deerfield management company, l.p. (series c) | 7.50M | 7.63% | $75.41M |
| Rubric capital management lp | 6.20M | 6.27% | $72.23M |
| Blackrock funding, inc. /de | 5.09M | 5.15% | $59.24M |
| Sr one capital management, lp | 4.01M | 4.06% | $46.75M |
| Abrdn | 3.56M | 3.60% | $41.43M |
| Vanguard group | 3.51M | 3.55% | $40.88M |
| State street | 2.90M | 2.94% | $29.10M |
| Alliancebernstein | 2.64M | 2.69% | $26.55M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Sr one capital management, lp | 4.01M | 6.62% | $46.75M |
| Bioimpact capital | 1.30M | 2.14% | $13.10M |
| Orbimed advisors | 8.29M | 1.96% | $83.30M |
| Nextech invest | 936.73K | 1.60% | $9.88M |
| Ra capital management | 10.86M | 1.34% | $109.15M |
| Casdin capital | 1.60M | 1.34% | $16.08M |
| Deerfield management company, l.p. (series c) | 7.50M | 1.15% | $75.41M |
| Lisanti capital growth | 396.51K | 1.09% | $4.62M |
| Nextech invest | 660.70K | 1.01% | $6.64M |
| Investment management associates inc /adv | 311.50K | 1.00% | $3.63M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Rubric capital management lp | 6.20M | 0.86% | 1.70M |
| Casdin capital | 1.60M | 1.34% | 1.60M |
| Ubs group | 2.21M | 0.00% | 1.55M |
| Bamco inc /ny/ | 1.27M | 0.03% | 1.23M |
| Qube research | 1.03M | 0.01% | 1.03M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deerfield management company, l.p. (series c) | 7.50M | 1.15% | -2.22M |
| Adage capital partners gp | - | - | -1.73M |
| Wellington management group llp | - | - | -1.43M |
| Octagon capital advisors lp | - | - | -1.35M |
| Alliancebernstein | 2.64M | 0.01% | -1.18M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Casdin capital | 1.60M | 1.34% | 1.60M | $16.08M |
| Qube research | 1.03M | 0.01% | 1.03M | $10.40M |
| Eversept partners, lp | 976.51K | 0.68% | 976.51K | $9.81M |
| Bank of montreal /can/ | 643.41K | 0.00% | 643.41K | $7.50M |
| Investment management associates inc /adv | 311.50K | 1.00% | 311.50K | $3.63M |
Sold Out
| Holder | Change |
|---|---|
| National bank of canada /fi/ | -1.00 |
| Principal securities | -17.00 |
| True wealth design | -21.00 |
| Stephens consulting | -30.00 |
| Capital performance advisors llp | -33.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 144 | -28.00% | 49,264,084 | -41.09% | 49 | 0.69% | 69 | -39.47% | 42 | -10.64% |
| Sep 30, 2025 | 196 | 1.03% | 83,443,647 | -1.27% | 84 | 1.15% | 111 | -1.77% | 46 | - |
| Jun 30, 2025 | 192 | 1.59% | 84,508,656 | 10.87% | 85 | 1.42% | 111 | 12.12% | 46 | -16.36% |
| Mar 31, 2025 | 188 | 8.05% | 76,205,334 | 6.92% | 77 | 1.44% | 99 | 2.06% | 54 | 20.00% |
| Dec 31, 2024 | 164 | 1.23% | 68,247,890 | 6.54% | 70 | 1.61% | 88 | -14.56% | 44 | 69.23% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| State Street® SPDR® S&P® Biotech ETF | 1.98M | 2.00% | -10.67K |
| Vanguard US Total Market Shares ETF | 1.86M | 1.90% | - |
| Vanguard Total Stock Mkt Idx Inv | 1.75M | 1.77% | - |
| Franklin Biotechnology Discv A(acc)USD | 1.56M | 1.58% | - |
| abrdn Healthcare Opportunities | 1.42M | 1.43% | -103.33K |
| abrdn Healthcare Investors | 1.42M | 1.43% | - |
| iShares Russell 2000 ETF | 1.42M | 1.43% | 1.42M |
| Baron Discovery Strategy | 1.07M | 1.09% | - |
| Baron Discovery Institutional | 1.07M | 1.09% | - |
| AB Small Cap Growth A | 1.05M | 1.06% | -56.95K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 13, 2025 | Dorsey Brian | Chief Operating Officer | Sell | $190.05K |
| Nov 12, 2025 | Chakma Justin | Chief Business Officer | Sell | $267.36K |
| Nov 12, 2025 | Chakma Justin | Chief Business Officer | Sell | $1.21M |
| Aug 21, 2025 | Lowenthal Richard E | PRESIDENT AND CEO | Sell | $724.35K |
| Aug 21, 2025 | Scott Kathleen D. | Chief Financial Officer | Sell | $187.50K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | 3 |
| 2025 Q3 | - | 5 |
| 2025 Q2 | - | 6 |
| 2025 Q1 | - | 5 |
| 2024 Q4 | - | 58 |
SPRY Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools